More on sovereign immunity

A federal judge has thrown a bucket of cold water on Allergan plc’s attempt to shield its patents by transferring them to a Native American tribe.

The disdain for the deal expressed by William Bryson, a judge in the U.S. District Court for the Eastern District of Texas, increases pressure on the Patent Trial and Appeal Board (PTAB) to reject Allergan’s request that it dismiss challenges to Restasis cyclosporine patents brought under the board’s inter partes review (IPR) procedures. ...